Cargando…
Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa
Antibiotic discovery and preclinical testing are needed to combat the Pseudomonas aeruginosa health threat. Most frequently, antibiotic efficacy is tested in models of acute respiratory infection, with chronic pneumonia remaining largely unexplored. This approach generates serious concerns about the...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057181/ https://www.ncbi.nlm.nih.gov/pubmed/31624114 http://dx.doi.org/10.1183/13993003.02456-2018 |